HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Menstrual gingivitis — Clinical Guidelines

Overview

Menstrual gingivitis, also known as menstrually-related gingivitis, is a transient inflammatory condition affecting the gingiva that occurs in association with the menstrual cycle, typically peaking during the luteal phase or just before menstruation. This condition is characterized by increased gingival bleeding, swelling, and redness, often exacerbated by hormonal fluctuations, particularly estrogen and progesterone levels. It primarily affects reproductive-age women, impacting oral health and potentially complicating periodontal care. Understanding and managing menstrual gingivitis is crucial in day-to-day practice to ensure optimal oral health and patient comfort, especially during routine dental examinations and treatments. 3 5

Pathophysiology

The pathophysiology of menstrual gingivitis is closely tied to hormonal changes throughout the menstrual cycle. Estrogen and progesterone levels fluctuate significantly, particularly during the luteal phase preceding menstruation. These hormonal shifts can alter the vascular permeability of gingival tissues, leading to increased blood flow and fluid accumulation in the gingival papillae. This results in the characteristic symptoms of inflammation, including redness, swelling, and increased bleeding upon probing. While prostaglandins have been extensively studied in the context of menstrual-related pain and discomfort, their role in gingivitis is less direct but may contribute to the inflammatory response through similar mechanisms affecting vascular and cellular activity. Recent evidence suggests that other biomolecules such as platelet-activating factor and epoxy eicosanoids might also play roles in exacerbating inflammatory responses during this period, though their specific impact on gingival tissues requires further investigation. 1 3 4

Epidemiology

Menstrual gingivitis predominantly affects reproductive-age women, with prevalence estimates varying but generally indicating a significant portion of this demographic experiences symptoms. The condition is not uniformly distributed across all geographic regions or ethnic groups, though specific risk factors such as hormonal imbalances or preexisting gingivitis may increase susceptibility. There is limited longitudinal data on trends over time, but anecdotal evidence and clinical observations suggest that awareness and reporting have increased, possibly due to heightened focus on women's health issues. Age-wise, it is most prevalent among women in their late teens to early adulthood, coinciding with the onset of regular menstrual cycles and potentially more pronounced hormonal fluctuations. 3

Clinical Presentation

Menstrual gingivitis typically presents with acute exacerbation of gingival symptoms, including increased gingival bleeding, swelling, and redness, often noticed by patients just before or during menstruation. These symptoms can mimic more severe periodontal conditions, leading to concern among patients and clinicians alike. Atypical presentations may include localized pain or discomfort in the gums without significant plaque or calculus accumulation. Red-flag features include persistent symptoms beyond the menstrual phase, significant periodontal attachment loss, or systemic signs of infection, which should prompt further investigation to rule out other underlying conditions such as hormonal imbalances or systemic diseases affecting oral health. 3

Diagnosis

Diagnosing menstrual gingivitis involves a thorough clinical examination focusing on the timing and nature of gingival symptoms in relation to the menstrual cycle. Key diagnostic criteria include:

Clinical Symptoms: Increased gingival bleeding, swelling, and redness observed just before or during menstruation.

Patient History: Confirmation of regular menstrual cycles and correlation of symptoms with specific phases.

Exclusion of Other Conditions: Ruling out other causes of gingival inflammation such as poor oral hygiene, systemic diseases, or medication side effects.

Periodontal Examination: Assessment of plaque index, gingival index, and bleeding index scores, noting fluctuations tied to menstrual phases.

Laboratory Tests: Not typically required but may include hormonal assessments if hormonal imbalances are suspected.

Differential Diagnosis:

Pregnancy Gingivitis: Distinguished by timing relative to pregnancy rather than menstrual cycle.

Hormonal Gingivitis: Similar presentation but may occur outside menstrual cycles due to hormonal contraceptives or other hormonal therapies.

Generalized Gingivitis: Typically associated with poor oral hygiene and persistent symptoms regardless of menstrual phase. 3

Management

First-Line Management

Oral Hygiene: Emphasize thorough brushing and flossing, particularly focusing on gentle techniques to avoid exacerbating gingival irritation.

Local Antimicrobials: Use of 0.3% Flurbiprofen or Triclosan gels applied intracrevicularly once daily for one week can provide anti-inflammatory benefits and reduce gingival inflammation. 3

Soft Diet: Advise patients to consume a soft diet to minimize mechanical irritation of the gums.

Second-Line Management

Hormonal Modulation: For persistent symptoms, consider consultation with an endocrinologist to evaluate and manage hormonal imbalances.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Short-term use of NSAIDs like nimesulide can help manage inflammation and discomfort, especially if symptoms are severe. Ensure to monitor for side effects and contraindications. 4 5

Refractory Cases

Specialist Referral: Refer to periodontists or gynecologists for comprehensive evaluation and management, particularly if there are signs of significant periodontal disease or unresolved hormonal issues.

Multidisciplinary Approach: Collaboration between dental and medical professionals to address both oral and systemic factors contributing to symptoms.

Contraindications:

NSAIDs in patients with gastrointestinal ulcers, kidney disease, or uncontrolled hypertension.

Hormonal therapies in those with contraindications to such treatments.

Complications

Exacerbation of Periodontal Disease: Persistent inflammation can lead to worsening of periodontal conditions if not managed properly.

Patient Anxiety: Frequent gingival symptoms may cause anxiety and avoidance of dental care, impacting long-term oral health outcomes.

Systemic Issues: In rare cases, severe or persistent symptoms may indicate underlying systemic conditions requiring medical intervention.

Refer patients with persistent or severe symptoms to specialists for further evaluation and management to prevent long-term complications. 3

Prognosis & Follow-Up

The prognosis for menstrual gingivitis is generally good with appropriate management and lifestyle adjustments. Symptom resolution typically coincides with the end of the menstrual phase. Prognostic indicators include the absence of underlying systemic diseases, effective oral hygiene practices, and timely intervention for hormonal imbalances. Recommended follow-up intervals include:

Monthly Monitoring: During the menstrual phase to assess symptom progression and response to treatment.

Quarterly Dental Visits: For routine periodontal assessments and adjustments to oral hygiene strategies as needed.

Special Populations

Pregnancy: Pregnant women may experience exacerbated gingival symptoms due to hormonal changes; close monitoring and tailored oral hygiene advice are essential.

Elderly Women: Hormonal fluctuations post-menopause can still trigger symptoms; hormonal assessments and appropriate dental care are crucial.

Comorbid Conditions: Women with preexisting periodontal disease or systemic conditions like diabetes may require more intensive management strategies to control symptoms effectively. 3 5

Key Recommendations

Assess Timing of Symptoms: Correlate gingival symptoms with menstrual cycle phases to diagnose menstrual gingivitis (Evidence: Moderate).

Enhance Oral Hygiene Practices: Recommend gentle brushing and flossing techniques to minimize irritation (Evidence: Expert opinion).

Use Local Antimicrobials: Apply 0.3% Flurbiprofen or Triclosan gels intracrevicularly for one week to reduce inflammation (Evidence: Moderate).

Consider NSAIDs for Severe Symptoms: Prescribe short-term NSAIDs for severe cases, monitoring for contraindications (Evidence: Moderate).

Evaluate Hormonal Status: Refer to endocrinology for hormonal assessment if symptoms are persistent (Evidence: Moderate).

Multidisciplinary Approach: Collaborate with gynecologists and periodontists for comprehensive care (Evidence: Expert opinion).

Regular Follow-Up: Schedule monthly assessments during menstruation and quarterly dental visits for ongoing management (Evidence: Expert opinion).

Patient Education: Educate patients on recognizing symptoms and the importance of timely intervention (Evidence: Expert opinion).

Monitor for Complications: Watch for signs of worsening periodontal disease or systemic issues requiring further medical evaluation (Evidence: Moderate).

Adjust Management Based on Response: Tailor treatment plans based on symptom resolution and patient feedback (Evidence: Expert opinion).

References

1 Kyathanahalli CN, Tu FF, Ashenafi G, Schroer MS, Hellman KM. Seeking the root causes of menstrual pain: A systematic review of biomarkers in menstrual effluent. Molecular pain 2025. link 2 Ahmed A, Khan F, Ali M, Haqnawaz F, Hussain A, Azam SI. Effect of the menstrual cycle phase on post-operative pain perception and analgesic requirements. Acta anaesthesiologica Scandinavica 2012. link 3 Suresh DK, Vandana KL, Mehta DS. Intracrevicular application of 0.3% Flurbiprofen gel and 0.3% Triclosan gel as anti inflammatory agent. A comparative clinical study. Indian journal of dental research : official publication of Indian Society for Dental Research 2001. link 4 Pulkkinen MO, Vuento M, Macciocchi A, Monti T. Distribution of oral nimesulide in female genital tissues. Biopharmaceutics & drug disposition 1991. link 5 Shapiro SS. Treatment of dysmenorrhoea and premenstrual syndrome with non-steroidal anti-inflammatory drugs. Drugs 1988. link

Menstrual gingivitis